Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.
FDA sees promise in new AI model for heart attack detection
Powerful Medical's advanced algorithm was designed to detect STEMI and STEMI-equivalent patterns in a patient’s ECG results.
Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks
When patients require subsequent noncardiac surgery after a major heart operation, waiting at least 100 days is one way to limit the risk of an adverse event. Read the full analysis in JACC: Advances.
Abbott makes IVL move as FDA approves new clinical trial
Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

FDA announces Class I recall of battery packs for intra-aortic balloon pumps

According to multiple customer complaints, the battery packs are failing before they should. This creates the potential for significant complications, including death.

ACC, AHA release long-awaited chest pain guidelines

The new guidelines stress the importance of more complete chest pain evaluations, patient communication and shared decision-making.

Researchers, take note: Nonfatal MI not a surrogate for all-cause or cardiovascular mortality

The new study, published in JAMA Internal Medicine, examined data from 144 different randomized clinical trials.

Personalized clotting profiles could boost care for high-risk cardiac patients

The study, published in Blood Advances, suggests that a "one size fits all" approach to cardiac care could soon be a thing of the past.

Blood pressure targets may need to be personalized for each patient

“Our results suggest that BP targets may need to be modified depending on the CV outcome for which the patient is most at risk,” researchers said.

Functional iron deficiency an 'important risk factor' for CVD

The condition was also linked to all-cause mortality.

Task force: Aspirin not recommended to prevent first MI or stroke

Starting a daily aspirin regimen in people age 60 or older can cause potentially serious harm including internal bleeding, the USPSTF warned Tuesday.

New battery-powered device diagnoses heart attacks in just minutes

The portable sensor, developed by specialists at the University of Notre Dame and University of Florida, targets the patient's microRNA.

Acute Coronary Syndromes

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’

FDA sees promise in new AI model for heart attack detection

Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks

Abbott makes IVL move as FDA approves new clinical trial